Page last updated: 2024-08-22

ornithylaspartate and Sensation Disorders

ornithylaspartate has been researched along with Sensation Disorders in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Ferenci, P; Gangl, A; König, F; Mittermaier, C; Peck-Radosavljevic, M; Schmid, M	1

Trials

1 trial(s) available for ornithylaspartate and Sensation Disorders

Article	Year
A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis. Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:4 Topics: Aged; Ammonia; Biopsy, Needle; Dipeptides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Hepatic Encephalopathy; Humans; Immunohistochemistry; Infusions, Intravenous; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Pilot Projects; Postural Balance; Psychometrics; Reference Values; Risk Assessment; Sensation Disorders; Severity of Illness Index; Statistics, Nonparametric; Survival Rate; Treatment Outcome	2010

Article

Year

A double-blind, randomized, placebo-controlled trial of intravenous L-ornithine-L-aspartate on postural control in patients with cirrhosis.

Liver international : official journal of the International Association for the Study of the Liver, 2010, Volume: 30, Issue:4

Topics: Aged; Ammonia; Biopsy, Needle; Dipeptides; Dose-Response Relationship, Drug; Double-Blind Method; Drug Administration Schedule; Female; Follow-Up Studies; Hepatic Encephalopathy; Humans; Immunohistochemistry; Infusions, Intravenous; Liver Cirrhosis; Liver Function Tests; Male; Middle Aged; Pilot Projects; Postural Balance; Psychometrics; Reference Values; Risk Assessment; Sensation Disorders; Severity of Illness Index; Statistics, Nonparametric; Survival Rate; Treatment Outcome

2010